Primary Record
h-89
- In stock
- 9,923 g
- Purity
- 98.5 %
- CAS
- 127243-85-0
Compound Identifiers & Properties
- CAS
- 127243-85-0
- PubChem CID
- 449241
- SMILES
- C1=CC2=C(C=CN=C2)C(=C1)S(=O)(=O)NCCNC/C=C/C3=CC=C(C=C3)Br
- Canonical SMILES
- O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12
Names & Synonyms
- h-89
- 127243-85-0
- 1ydt
- H 89
- C20H20BrN3O2S
- H-89 DIHYDROCHLORIDE
- H-89 free base?
- H 89 dihydrochloride
- H89 dihydrochloride/
- H-89 (E-isomer)
- H-89, Dihydrochloride
- AC1L9MWD
- BiomolKI_000035
- RefChem:869976
- Protein kinase inhibitor H-89
- Protein kinase inhibitor H89
- BiomolKI2_000043
- D09FFE
- CHEMBL104264
- DTXSID801022528
- H-89 (hydrochloride salt)
- Lopac0_000140
- BSPBio_001107
- H-89 dihydrochloride hydrate
- SCHEMBL123495
- ZKZXNDJNWUTGDK-NSCUHMNNSA-N
- BMK1-D11
- GTPL5983
- UNII-M876330O56
- protein kinase A inhibitor H89
- BDBM15211
- CHEBI:47495
- BRD7647
- CHEBI:191396
- N-(2-(4-Bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide
- BCPP000214
- DTXCID601507213
- HMS1362G09
- HMS1792G09
- HMS1990G09
- HMS3403G09
- BCP02706
- BRD-7647
- EX-A2432
- ZINC2043204
- C20-H20-Br-N3-O2-S
- 3896AH
- ABP000806
- CID449241
- EI-196
- MFCD00214119
- MFCD00214120
- NSC755766
- NSC782017
- H 87
- H-87
- AKOS025394289
- AKOS037647444
- BCP9000757
- CCG-100639
- CID:449241
- CS-3386
- DB07995
- LS40144
- NSC-755766
- NSC-782017
- SDCCGSBI-0050128.P005
- IDI1_002139
- M876330O56
- NCGC00162073-01
- NCGC00162073-02
- NCGC00162073-03
- NCGC00162073-04
- NCGC00162073-07
- NCGC00162073-13
- NCGC00162073-14
- AC-27757
- AJ-33335
- AS-73687
- HY-15979
- N-[2-[[(E)-3-(4-bromophenyl)prop-2-enyl]amino]ethyl]isoquinoline-5-sulfonamide
- SID:53788420
- N-[2-(P-BROMOCINNAMYLAMINO)ETHYL]-5-ISOQUINOLINE SULFONAMIDE
- J487.059J
- J749.446G
- LS-172674
- RT-013181
- NS00068838
- A11935
- S-7693
- 5-Isoquinolinesulfonamide, N-[2-[[3-(4-bromophenyl)-2-propen-1-yl]amino]ethyl]-
- H-89, Dihydrochloride - CAS 127243-85-0
- H89
- N-[2-(4-BROMOCINNAMYLAMINO)ETHYL]-5-ISOQUINOLINE SULFONAMIDE
- A805668
- C063509
- N-(2-{[(2E)-3-(4-bromophenyl)prop-2-en-1-yl]amino}ethyl)isoquinoline-5-sulfonamide
- CAS No. 130964-39-5 (H-89)
- N-(2-{[3-(4-bromophenyl)prop-2-en-1-yl]amino}ethyl)isoquinoline-5-sulfonamide
- Q5627831
- BRD-K27737647-001-04-2
- BRD-K27737647-300-01-4
- BRD-K27737647-300-03-0
- BRD-K27737647-300-04-8
- BRD-K27737647-300-08-9
- N-(2-((3-(4-Bromophenyl)allyl)amino)ethyl)isoquinoline-5-sulfonamide
- N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide
- N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide
- 5-Isoquinolinesulfonamide, N-(2-((3-(4-bromophenyl)-2-propenyl)amino)ethyl)-
- N-(2-((3-(4-Bromophenyl)-2-propenyl)amino)ehtyl)-5-isoquinolinesulfonamide dihydrochloride
- n-(2-[p-bromocinnamylamino]ethyl)-5-isoquinolinesulfonamide
- N-[2-(4-Bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide
- N-[2-[p-Bromocinnamylamino]ethyl]-5-isoquinolinesulfonmide
- (E)-N-(2-((3-(4-bromophenyl)allyl)amino)ethyl)isoquinoline-5-sulfonamide
- N-[2-[[(E)-3-(4-bromophenyl)allyl]amino]ethyl]isoquinoline-5-sulfonamide
- (E)-N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide
- N-[2-(p-Bromocinnamylamino)ethyl]-5-Isoquinoline Sulfonamide, 98%
- N-[2-[[3-(4-Bromophenyl)-2-propen-1-yl]amino]ethyl]-5-isoquinolinesulfonamide
- IQB
- n-[2-(p-bromocinnamylamino) ethyl]-5-isoquinolinesulfonamide dihydrochloride
- N-[2-(p-Bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide dihydrochloride
- n-[2-[[3-(4-bromophenyl)-2-propenyl]amino]ethyl]-5-isoquinolinesulfonamide
- N-[2-[3-(4-bromophenyl)prop-2-enylamino]ethyl]isoquinoline-5-sulfonamide
- 5-ISOQUINOLINESULFONAMIDE, N-(2-((3-(4-BROMOPHENYL)-2-PROPEN-1-YL)AMINO)ETHYL)-
- H-89 dihydrochloride, 98%, a potent and selective inhibitor of PKA - 10MG 10mg
- N-(2-((3-(4-Bromophenyl)allyl)amino)ethyl)isoquinoline-5-sulfonamide dihydrochloride
- 1000995-75-4
- 130964-39-5